Sign In
Buy KALV
$26.95
+0.0100 (+0.0371%)
At Close: Jun 03, 2026
Prospects Appear Bright for Small Drug Industry in 2020
01:41pm, Tuesday, 21'st Jan 2020
Prospects Appear Bright for Small Drug Industry in 2020
Prospects Appear Bright for Small Drug Industry in 2020
01:41pm, Tuesday, 21'st Jan 2020
Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity keep small drugmakers afloat in a competitive market.
Introducing KalVista Pharmaceuticals (NASDAQ:KALV), The Stock That Zoomed 123% In The Last Three Years
01:29pm, Monday, 06'th Jan 2020
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Here is What Hedge Funds Think About KalVista Pharmaceuticals, Inc. (KALV)
12:37am, Friday, 13'th Dec 2019
We can judge whether KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's
KalVista Pharmaceuticals, Inc. (KALV) Shares March Higher, Can It Continue?
12:42pm, Friday, 06'th Dec 2019
As of late, it has definitely been a great time to be an investor in KalVista Pharmaceuticals, Inc. (KALV).
Should You Be Concerned About KalVista Pharmaceuticals, Inc.'s (NASDAQ:KALV) Historical Volatility?
02:57pm, Thursday, 05'th Dec 2019
If you're interested in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), then you might want to consider its beta (a...
